Treatment of metabolic disorders in equine animals

Treatment of metabolic disorders in equine animals

The present invention relates to one or more SGLT2 inhibitors or pharmaceutically acceptable forms thereof for use in the treatment and/or prevention of a metabolic disorder of an equine animal. In particular, the present invention relates to one or more SGLT2 inhibitors or a pharmaceutically accept...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Laura JOHNSTON, Dania Birte REICHE, Bruce SOMERVILLE, Nicole MOHREN, Rebecca K VOTH
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Laura JOHNSTON
Dania Birte REICHE
Bruce SOMERVILLE
Nicole MOHREN
Rebecca K VOTH
description The present invention relates to one or more SGLT2 inhibitors or pharmaceutically acceptable forms thereof for use in the treatment and/or prevention of a metabolic disorder of an equine animal. In particular, the present invention relates to one or more SGLT2 inhibitors or a pharmaceutically acceptable form thereof for 5 use in the treatment and/or prevention of laminitis, vascular dysfunction, hypertension, hepatic lipidosis, atherosclerosis, hyperadrenocorticism, Pituitary Pars Intermedia Dysfunction and/or Equine Metabolic Syndrome in an equine animal.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2023266287A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2023266287A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2023266287A13</originalsourceid><addsrcrecordid>eNrjZDAKKUpNLMlNzStRyE9TyE0tSUzKz8lMVkjJLM4vSkktKlbIzFNILSzNzEtVSMzLzE3MKeZhYE0DUqm8UJqbQdnNNcTZQze1ID8-tbggMTk1L7Uk3jHUyMDI2MjMzMjC3NHQmDhVAIMaLQA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Treatment of metabolic disorders in equine animals</title><source>esp@cenet</source><creator>Laura JOHNSTON ; Dania Birte REICHE ; Bruce SOMERVILLE ; Nicole MOHREN ; Rebecca K VOTH</creator><creatorcontrib>Laura JOHNSTON ; Dania Birte REICHE ; Bruce SOMERVILLE ; Nicole MOHREN ; Rebecca K VOTH</creatorcontrib><description>The present invention relates to one or more SGLT2 inhibitors or pharmaceutically acceptable forms thereof for use in the treatment and/or prevention of a metabolic disorder of an equine animal. In particular, the present invention relates to one or more SGLT2 inhibitors or a pharmaceutically acceptable form thereof for 5 use in the treatment and/or prevention of laminitis, vascular dysfunction, hypertension, hepatic lipidosis, atherosclerosis, hyperadrenocorticism, Pituitary Pars Intermedia Dysfunction and/or Equine Metabolic Syndrome in an equine animal.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231207&amp;DB=EPODOC&amp;CC=AU&amp;NR=2023266287A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20231207&amp;DB=EPODOC&amp;CC=AU&amp;NR=2023266287A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Laura JOHNSTON</creatorcontrib><creatorcontrib>Dania Birte REICHE</creatorcontrib><creatorcontrib>Bruce SOMERVILLE</creatorcontrib><creatorcontrib>Nicole MOHREN</creatorcontrib><creatorcontrib>Rebecca K VOTH</creatorcontrib><title>Treatment of metabolic disorders in equine animals</title><description>The present invention relates to one or more SGLT2 inhibitors or pharmaceutically acceptable forms thereof for use in the treatment and/or prevention of a metabolic disorder of an equine animal. In particular, the present invention relates to one or more SGLT2 inhibitors or a pharmaceutically acceptable form thereof for 5 use in the treatment and/or prevention of laminitis, vascular dysfunction, hypertension, hepatic lipidosis, atherosclerosis, hyperadrenocorticism, Pituitary Pars Intermedia Dysfunction and/or Equine Metabolic Syndrome in an equine animal.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDAKKUpNLMlNzStRyE9TyE0tSUzKz8lMVkjJLM4vSkktKlbIzFNILSzNzEtVSMzLzE3MKeZhYE0DUqm8UJqbQdnNNcTZQze1ID8-tbggMTk1L7Uk3jHUyMDI2MjMzMjC3NHQmDhVAIMaLQA</recordid><startdate>20231207</startdate><enddate>20231207</enddate><creator>Laura JOHNSTON</creator><creator>Dania Birte REICHE</creator><creator>Bruce SOMERVILLE</creator><creator>Nicole MOHREN</creator><creator>Rebecca K VOTH</creator><scope>EVB</scope></search><sort><creationdate>20231207</creationdate><title>Treatment of metabolic disorders in equine animals</title><author>Laura JOHNSTON ; Dania Birte REICHE ; Bruce SOMERVILLE ; Nicole MOHREN ; Rebecca K VOTH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2023266287A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>Laura JOHNSTON</creatorcontrib><creatorcontrib>Dania Birte REICHE</creatorcontrib><creatorcontrib>Bruce SOMERVILLE</creatorcontrib><creatorcontrib>Nicole MOHREN</creatorcontrib><creatorcontrib>Rebecca K VOTH</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Laura JOHNSTON</au><au>Dania Birte REICHE</au><au>Bruce SOMERVILLE</au><au>Nicole MOHREN</au><au>Rebecca K VOTH</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Treatment of metabolic disorders in equine animals</title><date>2023-12-07</date><risdate>2023</risdate><abstract>The present invention relates to one or more SGLT2 inhibitors or pharmaceutically acceptable forms thereof for use in the treatment and/or prevention of a metabolic disorder of an equine animal. In particular, the present invention relates to one or more SGLT2 inhibitors or a pharmaceutically acceptable form thereof for 5 use in the treatment and/or prevention of laminitis, vascular dysfunction, hypertension, hepatic lipidosis, atherosclerosis, hyperadrenocorticism, Pituitary Pars Intermedia Dysfunction and/or Equine Metabolic Syndrome in an equine animal.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2023266287A1
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Treatment of metabolic disorders in equine animals
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T22%3A56%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Laura%20JOHNSTON&rft.date=2023-12-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2023266287A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true